HJY-21

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameHJY-21
Drug Alias NamePCSK9 siRNA therapy (Hygieia Pharmaceuticals)HJY-21
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Hygieia Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Hygieia Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A